Trial · NCT03446040
Adverse events2,896
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,896
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 8 mg | 1 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 24 mg | 0 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 72 mg | 1 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 200 mg | 1 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 480 mg | 0 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 800 mg | 0 | 9 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 1200 mg | 0 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 1600 mg | 0 | 5 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BMS-986258 2400 mg | 2 | 8 | |
| other | Anaemia | Blood and lymphatic system disorders | Part B: BMS-986258 480 mg + NIVO 480 mg | 0 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part B: BMS-986258 800 mg + NIVO 480 mg | 0 | 11 | |
| other | Anaemia | Blood and lymphatic system disorders | Part B: BMS-986258 1200 mg + NIVO 480 mg | 1 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Part B: BMS-986258 1600 mg + NIVO 480 mg | 1 | 15 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A1: BMS-986258 1200 mg + ENHANZE | 0 | 11 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A1 Crossover to Part B: 1200 mg BMS + 480 mg Nivo | 0 | 2 | |
| other | Anaemia | Blood and lymphatic system disorders | Part A1 Crossover to Part B: 1600 mg BMS + 480 mg Nivo | 2 | 2 | |
| other | Neutropenia | Blood and lymphatic system disorders | Part A: BMS-986258 8 mg | 0 | 3 | |
| other | Neutropenia | Blood and lymphatic system disorders | Part A: BMS-986258 24 mg | 0 | 3 | |
| other | Neutropenia | Blood and lymphatic system disorders | Part A: BMS-986258 72 mg | 0 | 4 | |
| other | Neutropenia | Blood and lymphatic system disorders | Part A: BMS-986258 200 mg | 0 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03446040/events